Anti-SARS-CoV/SARS-CoV-2 Nucleocapsid Protein Rabbit Monoclonal (Clone 0002)

Severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 nucleocapsid proteins are encoded by the N gene in SARS-CoV and SARS-CoV-2 RNA. SARS-CoV and SARS-CoV-2 are members of the Betacoronavirus genus of viruses that have approximately 79% sequence identity and share 27 T cell epitopes in common. The SARS-CoV-2 nucleocapsid protein has greater than 90% similarity to the SARS-CoV nucleocapsid protein and contains two unique B cell epitopes and two T cell epitopes that are structurally stable, non-allergenic, and induce production of IFN-gamma. SARS-CoV and SARS-CoV-2 nucleocapsid proteins package the viral RNA into a helical ribonucleoprotein complex (RNP), which is a template for viral replication, and are integral for viral self-assembly and involved in regulation of the host cell cycle. SARS-CoV and SARS-CoV-2 are the causative agents of SARS and COVID-19, respectively, both of which are primarily respiratory illnesses characterized by fever, cough, and shortness of breath that can lead to life-threatening complications. Cayman's SARS-CoV/SARS-CoV-2 Nucleocapsid Protein Rabbit Monoclonal Antibody (Clone 0002) can be used for ELISA, ELISA (capture), and Western blot (WB, reducing conditions) applications. This recombinant antibody recognizes nucleocapsid protein at 45.6 kDa from SARS-CoV and SARS-CoV-2.Synonyms: SARS-CoV/SARS-CoV-2 NP, SARS-CoV/SARS-CoV-2 Nucleoprotein, Severe Acute Respiratory Syndrome Coronavirus /Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Protein. Immunogen: Recombinant SARS-CoV-2 nucleocapsid protein. Clone Designation: 0002. MW: 45.6 kDa. Formulation: (Request formulation change), 100 µl of protein A-purified recombinant monoclonal antibody. Storage Buffer: 0.2 µm filtered solution in PBS. Host: Rabbit. Isotype: IgG. Applications: ELISA, ELISA (capture), WB (reducing conditions).